ℹ️
🇬🇧
Search
Search for publications relevant for "Abcg2"
Abcg2
Publication
Class
Person
Publication
Programmes
Export current view
publication
Effect of ABCG2 on cytotoxicity of platinum drugs: Interference of EGFP
2008 |
Central Library of Charles University
publication
Functional non-synonymous variants of ABCG2 and gout risk
2017 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
2019 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis
2016 |
First Faculty of Medicine
publication
Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone
2012 |
Faculty of Pharmacy in Hradec Králové
publication
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
2019 |
First Faculty of Medicine
publication
Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Interaction of the p.Q141K Variant of the ABCG2 Gene with Clinical Data and Cytokine Levels in Primary Hyperuricemia and Gout
2019 |
First Faculty of Medicine, Faculty of Science, Faculty of Mathematics and Physics
publication
Effect of ABCG2 on cytotoxicity of platinum drugs: Interference of EGFP
2008 |
Faculty of Pharmacy in Hradec Králové, Central Library of Charles University
publication
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout
2021 |
First Faculty of Medicine
publication
Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort
2019 |
Central Library of Charles University, First Faculty of Medicine, Faculty of Science, Faculty of Mathematics and Physics
publication
Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics
2019 |
Faculty of Pharmacy in Hradec Králové
publication
Lack of Interactions between Breast Cancer Resistance Protein (BCRP/ABCG2) and Selected Antiepileptic Agents
2006 |
First Faculty of Medicine
publication
Etravirine inhibits ABCG2 drug transporter and affects transplacental passage of tenofovir disoproxil fumarate
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy
2022 |
Faculty of Pharmacy in Hradec Králové
publication
A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer
2008 |
First Faculty of Medicine
publication
Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Sonidegib potentiates the cancer cells' sensitivity to cytostatic agents by functional inhibition of ABCB1 and ABCG2 in vitro and ex vivo
2022 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Long-term administration of tenofovir or emtricitabine to pregnant rats; effect on Abcb1a, Abcb1b and Abcg2 expression in the placenta and in maternal and fetal organs
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme
2020 |
Faculty of Pharmacy in Hradec Králové
publication
Severe hyperuricemia in two children with acute gastroenteritis: answers
2020 |
First Faculty of Medicine
publication
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs)
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study
2022 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): Expression and function throughout pregnancy
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo
2006 |
Faculty of Pharmacy in Hradec Králové, Central Library of Charles University